EcoDrugPlus

Solute Carrier Family 5 Member 1

Ensembl ID : ENSUMAG00000015760
Gene Symbol: SLC5A1
4 Cross references
250 Possible Orthologues:

Solute Carrier Family 5 Member 2

Ensembl ID : ENSUMAG00000014553
Gene Symbol: SLC5A2
4 Cross references
197 Possible Orthologues:

Solute Carrier Family 6 Member 1

Ensembl ID : ENSUMAG00000017999
Gene Symbol: SLC6A1
4 Cross references
276 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSUMAG00000001816
Gene Symbol: SLC6A2
4 Cross references
202 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSUMAG00000021572
Gene Symbol: SLC6A3
4 Cross references
166 Possible Orthologues:

Solute Carrier Family 6 Member 4

Ensembl ID : ENSUMAG00000010528
Gene Symbol: SLC6A4
4 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSUMAG00000024324
Gene Symbol: SLC6A9
4 Cross references
207 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSUMAG00000022137
Gene Symbol: SLC9A3
4 Cross references
234 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSUMAG00000008405
Gene Symbol: SSTR1
4 Cross references
158 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSUMAG00000007822
Gene Symbol: SSTR2
4 Cross references
263 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSUMAG00000004048
Gene Symbol: SSTR4
4 Cross references
100 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSUMAG00000000680
Gene Symbol: SPHK2
2 Cross references
209 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).